OakChart

Resmed Inc

RMDHealthcare·Medical Instruments & Supplies·USA·Large·NYSE·Nov 11 • 3:59 PM ET

238.53+4.42 (1.89%)
2026-11-11 23:22 CET
Market cap
32,929.21 USD m
Revenue, TTM
5,732.68 USD m
Net income, TTM
1,593.17 USD m
Free cash flow, TTM
1,608.87 USD m
EPS diluted, TTM
10.98
P/E
21.72
Compare

Price

RMD against its 20, 50 and 200-day averages
2050200beatmiss
180.00200.00220.00240.00260.001.9M3.9MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26RMDclose 238.5320-day 241.9550-day 231.79200-day 224.05238.5352w low

14.1% under the 52-week high of 277.67 on 10 Feb 2026. 52-week low 180.27 on 2 Jun 2026. Last 15 sessions, 15.3% high to low

Volume 0.70× normal · the line is the 50-bar volume average

Profile

RMD
52-week range, 60% of the way up
180.26277.67

ResMed, Inc. engages in the design, manufacture, and marketing of equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory disorders, as well as the provision of software solutions for residential care providers. It operates through the following segments: Sleep and Breathing Health and Residential Care Software. The Sleep and Breathing Health segment relates primarily to the sale of therapy-based equipment. The Residential Care Software segment provides software access with ongoing support and maintenance services as well as professional services such as training and consulting. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

IndexS&P 500, RUI
Employees11370
IPOJun 02, 1995
Beta0.76
ATR, 14d7.81
Rel volume0.70
Short float7.52%
Insider own0.94%
Inst own74.21%

Snapshot

6 groups

Valuation

IndexS&P 500, RUI
Market Cap33.55B
Enterprise Value33.13B
Income1.59B
Sales5.73B
Book/sh42.29
Cash/sh7.32
Dividend Est.2.67 (1.12%)
Dividend TTM2.46 (1.03%)
Dividend Ex-DateNov 12, 2026
Dividend Gr. 3/5Y10.89% 9.00%
Payout23.01%
Employees11370
IPOJun 02, 1995

Ratios

P/E21.72
Forward P/E18.00
PEG1.98
P/S5.85
P/B5.64
P/C32.60
P/FCF20.85
EV/EBITDA15.17
EV/Sales5.78
Quick Ratio1.88
Current Ratio2.65
Debt/Eq0.10
LT Debt/Eq0.07
Option/ShortYes / Yes

Earnings

EPS (ttm)10.98
EPS next Y13.25
EPS next Q2.99
EPS this Y8.65%
EPS next Y9.19%
EPS next 5Y9.08%
EPS past 3/5Y19.66% 26.34%
Sales past 3/5Y10.21% 12.08%
EPS Y/Y TTM12.22%
Sales Y/Y TTM9.04%
EPS Q/Q22.97%
Sales Q/Q5.93%
EarningsOct 29 AMC
EPS/Sales Surpr.8.33% 1.47%

Ownership

Insider Own0.94%
Insider Trans-2.89%
Inst Own74.21%
Inst Trans0.40%
ROA19.29%
ROE26.40%
ROIC25.02%
Gross Margin60.49%
Oper. Margin33.94%
Profit Margin27.79%
SMA20-1.41%
SMA502.91%
SMA2006.46%
Trades-

Technical

Shs Outstand140.64M
Shs Float139.33M
Short Float7.52%
Short Ratio7.89
Short Interest10.47M
52W High277.67 -14.10%
52W Low180.26 32.32%
Volatility3.24% 2.83%
ATR (14)7.81
RSI (14)51.47
Beta0.76
Rel Volume0.70
Avg Volume1.33M
Volume930,452

Performance

Perf Week-0.82%
Perf Month1.48%
Perf Quarter5.20%
Perf Half Y17.87%
Perf YTD-0.97%
Perf Year-5.51%
Perf 3Y66.11%
Perf 5Y-5.83%
Perf 10Y298.55%
Recom2.17
Target Price272.76
Prev Close234.11
Price238.53
Change %1.89%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Nov 02, 2026DowngradeCCanaccord GenuityBuy → Hold
Sep 15, 2026UpgradeRRBC Capital MktsSector Perform → Outperform$262+9.8%
Aug 19, 2026InitiatedRRothschild & Co RedburnNeutral$230-3.6%
Jul 16, 2026DowngradeRRBC Capital MktsOutperform → Sector Perform$234-1.9%
Jul 13, 2026DowngradeCCitigroupBuy → Neutral$235-1.5%
Jun 17, 2026DowngradeMMorgan StanleyOverweight → Equal-Weight$230-3.6%
Apr 15, 2026InitiatedJJP MorganOverweight
Dec 16, 2025DowngradeRRobert W. BairdOutperform → Neutral$275+15.3%
Sep 18, 2025InitiatedCCitigroupBuy$330+38.3%
Sep 02, 2025UpgradeCCLSAHold → Outperform

Peers

Mkt cap
TickerCompanyMkt cap
PHGKoninklijke Philips NV ADR29.52B
INSPInspire Medical Systems Inc1.80B
DXCMDexcom Inc29.96B
INGNInogen Inc149.51M
AHCOAdaptHealth Corp1.06B
MDTMedtronic Plc129.98B
VMDViemed Healthcare Inc345.96M
LIVNLivaNova PLC5.01B
ACHAccendra Health Inc11.18M
LLYLilly(Eli) & Co1352.12B

Insider trading

latest 14 of 72
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Farrell Michael J.OfficerNov 09 '26Proposed Sale235.354,9931,175,089Nov 09 04:10 PM
Rider Michael JGlobal General CounselOct 23 '26Sale255.00400102,00012,318Oct 26 03:39 PM
Rider Michael JOfficerOct 23 '26Proposed Sale255.00400102,000Oct 23 12:28 PM
Farrell Michael J.Chairman and CEOOct 07 '26Option Exercise146.344,991730,383484,794Oct 08 05:31 PM
Farrell Michael J.Chairman and CEOOct 07 '26Sale226.334,9911,129,637479,803Oct 08 05:31 PM
Farrell Michael J.OfficerOct 07 '26Proposed Sale226.334,9911,129,638Oct 07 04:22 PM
Farrell Michael J.Chairman and CEOSep 08 '26Option Exercise146.344,991730,383471,247Sep 10 06:40 AM
Farrell Michael J.Chairman and CEOSep 08 '26Sale222.444,9911,110,191466,256Sep 10 06:40 AM
Farrell Michael J.OfficerSep 08 '26Proposed Sale226.224,9911,129,064Sep 08 01:21 PM
FARRELL PETER CDirectorSep 02 '26Sale234.73970227,68851,803Sep 04 06:30 AM
Peter C FarrellDirectorSep 02 '26Proposed Sale234.65970227,608Sep 02 07:16 PM
Farrell Michael J.Chairman and CEOAug 07 '26Option Exercise146.344,991730,383471,247Aug 11 06:30 AM
Farrell Michael J.Chairman and CEOAug 07 '26Sale205.694,9911,026,596466,256Aug 11 06:30 AM
Farrell Michael J.OfficerAug 07 '26Proposed Sale205.694,9911,026,596Aug 07 10:58 AM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VOOVanguard S&P 500 ETFAUM: 1054.75B
VOVanguard Morningstar Mid-Cap ETFAUM: 107.07B
IVViShares Core S&P 500 ETFAUM: 871.38B
SPYSPDR S&P 500 ETF TrustAUM: 793.23B
RDVYFirst Trust Rising Dividend Achievers ETFAUM: 25.61B
VUGVanguard Morningstar Growth ETFAUM: 217.67B
VOTVanguard Morningstar Mid-Cap Growth ETFAUM: 18.66B
XLVState Street Health Care Select Sector SPDR ETFAUM: 50.35B
RSPInvesco S&P 500 Equal Weight ETFAUM: 104.94B

News

latest 14 of 100

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2027Q12026-10-292.9102.6862.9201,4151,39417
2026Q42026-08-062.9502.8932.6451,4641,46118
2026Q32026-04-302.8602.7952.7361,4311,42018
2026Q22026-01-292.8102.7452.6821,4231,40117
2026Q12025-10-302.5502.5172.3731,3361,33316
2025Q42025-07-312.5502.5502.5821,3481,3481
2025Q32025-04-232.3702.3782.4801,2921,28816
2025Q22025-01-302.4302.3162.3371,2821,26714
2025Q12024-10-242.2002.0542.1101,2251,18512
2024Q42024-08-012.0802.0831.9811,2231,21812
2024Q32024-04-252.1301.9282.0381,1971,17412
2024Q22024-01-241.8801.7761.4151,1631,15014
2024Q12023-10-261.6401.6191.4881,1021,10313
2023Q42023-08-031.6001.6791.5571,1221,14216
2023Q32023-04-271.6801.5921.5771,1171,05114
2023Q22023-01-261.6601.6051.5261,034996.112

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY3.6403.6072.8002,6072,603
2020FY4.7604.5084.2682,9572,944
2021FY5.3305.2953.2403,1973,120
2022FY5.7905.7115.3013,5783,577
2023FY6.4406.5056.0874,2234,238
2024FY7.7207.7276.9194,6854,680
2025FY9.5509.5119.5075,1465,128
2026FY11.17011.12510.4305,6535,650
2027FY-12.137--5,829
2028FY-13.252--6,193
2029FY-14.497--6,592
2030FY-15.477--7,063

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2027Q2S2026-11-0916321,4551,4371,479
2027Q2S2026-10-3016321,4551,4371,479
2027Q2S2026-10-2916101,4531,4411,473
2027Q2S2026-10-2616101,4531,4411,473
2027Q2S2026-10-2316101,4531,4411,473
2027Q2S2026-10-2117101,4521,4281,473
2027Q2S2026-10-19171101,4521,4281,473
2027Q2S2026-10-15170111,4511,4281,464
2027Q2S2026-10-12170111,4511,4281,464
2027Q2S2026-10-09170111,4511,4281,464
2027Q2S2026-09-28170111,4511,4281,464
2027Q2S2026-09-23170121,4511,4281,464
2027Q2S2026-09-21170121,4511,4281,464
2027Q2S2026-09-10170131,4511,4281,464

Estimate history

EPS, annual2.1922.84.2683.245.3016.0876.9199.50710.4310.9808
Period201820192020202120222023202420252026TTM
EPS, quarterly2.112.3372.482.5822.3732.6822.7362.6452.918
PeriodQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27
Sales, annual2340.1962606.5722957.0133196.8253578.1274222.9934685.2975146.3275653.4435732.68
Period201820192020202120222023202420252026TTM
Sales, quarterly1224.5091282.0891291.7361347.9931335.5821422.8081431.4061463.6471414.814
PeriodQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27
Shares, annual142.68143.655144.887145.648146.411147.064146.901146.385144.24140.639
Period201820192020202120222023202420252026MRQ
Shares, quarterly146.776146.856146.619146.385145.941145.662145.04144.24140.639
PeriodQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27

Income statement, annual

Currency USD, millions
MetricTTM2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue5,732.685,653.445,146.334,685.304,222.993,578.133,196.822,957.012,606.57
Cost of Goods Sold Incl. D&A2,264.702,247.172,136.632,076.511,909.351,584.891,388.801,269.321,144.92
Gross Profit3,467.983,406.273,009.702,608.782,313.641,993.231,808.021,687.691,461.65
Selling, General and Administrative Excl. Other1,522.501,483.331,322.301,224.661,161.64992.95895.67878.63825.66
Research and Development392.49378.29331.28307.52287.64253.57225.28201.95180.65
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income1,945.481,922.951,687.391,384.121,152.001,000.29912.35809.06635.99
Interest Expense--12.6160.0560.6222.3123.9940.3836.16
Unusual Expense23.5215.99-7.6054.03-9.130.00-5.0912.5969.84
Net Income Before Taxes2,011.781,919.421,677.571,264.801,101.66960.48883.66733.09518.85
Income Taxes418.61396.12276.84243.85204.11181.05409.16111.41114.25
Consolidated Net Income1,593.171,523.291,400.721,020.95897.56779.44474.50621.67404.59
Net Income From Continuing Operations1,593.171,523.291,400.721,020.95897.56779.44474.50621.67404.59
Net Income1,593.171,523.291,400.721,020.95897.56779.44474.50621.67404.59
EPS (Recurring)11.2210.519.477.186.045.303.224.333.14
EPS (Basic, Before Extraordinaries)11.0110.479.556.946.125.343.274.312.83
EPS (Diluted)10.9810.439.516.926.095.303.244.272.80
EBITDA2,183.792,167.101,923.201,600.331,348.521,194.131,103.87990.43786.78
Non-Operating Income (Expense)107.6112.46-4.82-5.241.15-17.49-9.79-23.01-11.15
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense89.0081.2269.8351.4546.2835.9940.5818.0225.41
Price To Earnings Ratio21.3221.3228.9729.4635.8839.5376.1144.9739.58
Price To Sales Ratio5.535.037.396.037.638.6111.299.466.76
Gross Margin60.4960.2558.4855.6854.7955.7156.5657.0756.08
Operating Margin33.9434.0132.7929.5427.2827.9628.5427.3624.40
Net Margin27.7926.9427.2221.7921.2521.7814.8421.0215.52
Shares Outstanding140.64144.24146.39146.90147.06146.41145.65144.89143.65
Market Capitalization32,929.2132,929.2137,829.7728,120.9432,104.4230,665.7235,873.1027,776.2617,498.25

Income statement, quarterly

Currency USD, millions
Metric2027Q12026Q42026Q32026Q22026Q12025Q42025Q32025Q2
Total Revenue1,414.811,463.651,431.411,422.811,335.581,347.991,291.741,282.09
Cost of Goods Sold Incl. D&A544.25612.93551.67555.85526.72539.85536.22541.86
Gross Profit870.57850.72879.73866.96808.86808.14755.51740.23
Selling, General and Administrative Excl. Other385.73396.08374.02366.67346.52351.57329.25322.99
Research and Development101.53105.7394.2790.9787.3286.4483.9481.37
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income484.84454.64505.71500.30462.35456.57426.27417.24
Interest Expense17.79-----3.184.79
Unusual Expense21.43-4.86-2.159.1013.94-1.920.15-4.44
Net Income Before Taxes539.15474.16502.31496.15446.79458.05417.69418.32
Income Taxes120.7490.73103.58103.5698.2678.3552.6573.70
Consolidated Net Income418.41383.43398.73392.59348.54379.70365.04344.62
Net Income From Continuing Operations418.41383.43398.73392.59348.54379.70365.04344.62
Net Income418.41383.43398.73392.59348.54379.70365.04344.62
EPS (Recurring)3.022.622.732.732.442.572.482.32
EPS (Basic, Before Extraordinaries)2.932.652.742.692.382.592.492.35
EPS (Diluted)2.922.642.742.682.372.582.482.34
EBITDA536.67509.76574.74562.62520.02530.86478.18473.14
Non-Operating Income (Expense)93.5414.67-5.554.95-1.61-0.44-5.251.43
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense23.2921.6921.1722.8616.7219.5519.0517.88
Price To Earnings Ratio21.3218.7922.1924.6528.7928.9726.4430.32
Price To Sales Ratio5.535.005.916.537.657.376.566.85
Gross Margin61.5358.1261.4660.9360.5659.9558.4957.74
Operating Margin34.2731.0635.3335.1634.6233.8733.0032.54
Net Margin29.5726.2027.8627.5926.1028.1728.2626.88
Shares Outstanding140.64144.24145.04145.66145.94146.39146.62146.86
Market Capitalization32,929.2128,268.5132,701.8035,158.8340,078.1837,829.7732,876.1833,570.78

Balance sheet, annual

Currency USD, millions
Metric2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Cash & Short Term Investments1,472.591,222.53238.36227.89273.71295.28463.16147.13188.70
Short Term Receivables1,084.95990.67875.46736.43601.64625.18484.10538.32483.68
Inventories945.80927.71822.25998.01743.91457.03416.92349.64268.70
Other Current Assets821.39364.70421.65405.50312.22197.26159.29110.28124.63
Total Current Assets4,324.743,505.612,357.722,367.831,931.481,574.761,523.461,145.371,065.72
Net Property, Plant & Equipment735.00718.29699.15665.81630.50592.07535.68387.46386.55
Total Investments and Advances157.3870.45151.32146.8258.3869.2444.1452.1041.23
Long-Term Note Receivable14.0514.5818.4510.088.846.216.964.59-
Intangible Assets3,362.313,511.543,327.963,322.642,282.392,320.482,338.492,378.401,284.13
Deferred Tax Assets329.25253.12203.57132.9779.7579.9041.0645.4853.82
Other Assets43.22100.81114.23105.56104.5385.4697.5894.28232.48
Total Assets8,965.958,174.396,872.396,751.715,095.854,728.124,587.384,107.683,063.92
Short Term Debt Incl. Current Port. of LT Debt289.0940.4135.1831.8231.7735.5933.2511.9911.47
Accounts Payable308.92278.16237.73150.76159.25138.01135.79115.7292.72
Income Tax Payable98.11132.27107.5272.2244.89307.9664.7573.25160.43
Other Current Liabilities698.99568.28530.23503.73453.39430.21368.97355.03246.63
Total Current Liabilities1,395.111,019.12910.65758.53689.30911.77602.76555.99511.25
Long Term Debt536.83811.41838.761,548.09885.78758.131,266.011,258.86269.99
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities64.6477.6879.3490.659.7111.3213.0111.3813.08
Other Liabilities383.98298.32179.60224.53150.31161.23208.56209.26210.62
Total Liabilities2,380.562,206.532,008.352,621.801,735.101,842.452,090.352,035.491,004.94
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity6,585.395,967.864,864.044,129.903,360.752,885.682,497.032,072.192,058.98
Total Shareholders Equity6,585.395,967.864,864.044,129.903,360.752,885.682,497.032,072.192,058.98
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity6,585.395,967.864,864.044,129.903,360.752,885.682,497.032,072.192,058.98
Total Liabilities & Stockholders Equity8,965.958,174.396,872.396,751.715,095.854,728.124,587.384,107.683,063.92
Book Value Per Share45.6640.7733.1128.0822.9519.8117.2314.4214.43
Tangible Book Value Per Share22.3516.7810.465.497.373.881.09-2.135.43
Full-Time Employees11,37010,6009,98010,1408,1607,9707,7707,2405,940
Price to Book Ratio5.546.836.077.789.1312.4411.148.657.15
Return on Assets17.7718.6214.9915.1515.8710.1914.3011.289.66
Return on Equity24.2725.8622.7023.9624.9617.6327.2119.5915.70
Return on Invested Capital21.3920.6617.9015.8118.3513.0216.5212.1513.55
Quick Ratio2.422.531.691.811.721.231.841.431.56
Current Ratio3.103.442.593.122.801.732.532.062.08

Cash flow, annual

Currency USD, millions
MetricTTM2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income1,593.171,523.291,400.721,020.95897.56779.44474.50621.67404.59
Depreciation238.31244.15235.81216.21197.56193.84191.52181.37150.79
Other Funds (Non Cash)53.10112.6398.32119.3260.3185.9469.2997.1380.72
Funds from Operations1,884.581,880.071,734.851,356.481,155.431,059.22735.31900.18636.11
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-113.65-74.2416.7444.78-462.13-708.081.41-97.92-177.05
Cash from Operating Activities1,770.931,805.831,751.591,401.26693.30351.15736.72802.25459.05
Capital Expenditures-182.57-177.17-100.64-114.86-134.00-156.04-116.83-105.94-77.34
Net Assets From Acquisitions-357.69-350.72-139.25-133.46-1,012.75-42.78-39.07-27.91-951.38
Sale of Fixed Assets and Businesses450.820.000.000.000.000.000.000.00-
Purchase or Sale of Investments-26.33-25.78-1.79-11.77-28.29-13.92-21.79-31.62-46.72
Purchase of Investments-29.08-28.54-6.42-12.77-32.23-20.72-21.79-31.62-46.72
Sale Or Maturity of Investments2.752.754.631.003.946.800.000.000.00
Other Uses4.100.000.00-9.700.00-17.180.00-14.40-0.26
Other Sources11.108.4841.630.0015.20-19.220.00-
Cash from Investing Activities-100.57-545.20-200.04-269.78-1,159.85-229.92-158.46-179.86-1,075.71
Cash Dividends Paid-356.87-349.66-310.88-282.32-258.28-245.34-226.71-225.09-211.71
Change in Capital Stock-1,416.45-625.53-225.59-96.9249.1447.3837.7948.1813.88
Repurchase of Common Pref Stock-1,486.40-700.04-300.02-150.010.000.000.000.00-22.84
Sale of Common Pref Stock69.9574.5074.4453.0949.1447.3837.7948.1836.73
Proceedsfrom Stock Options69.9574.5074.4453.0949.1447.3837.7948.1836.73
Issuance or Reduction of Debt, Net-260.00-10.00-40.00-730.00665.00122.00-522.00-94.01807.49
Change in Long Term Debt-260.00-10.00-40.00-730.00665.00122.00-522.00-94.01807.49
Issuance of Long Term Debt0.000.000.00105.001,070.00288.0090.001,190.001,519.23
Reduction of Long Term Debt-260.00-10.00-40.00-835.00-405.00-166.00-612.00-1,284.01-711.75
Net Financing Active Other Cash Flow-21.44-21.83-29.79-10.05-32.99-52.41-53.71-46.36-29.01
Other Financing Activities Uses-21.44-21.83-29.79-10.05-32.99-52.41-53.71-46.36-29.01
Cash from Financing Activities-2,054.76-1,007.03-606.25-1,119.29422.87-128.36-764.63-317.29580.64
Exchange Rate Effect11.296.1825.80-1.72-2.15-14.4318.5010.92-5.56
Net Change in Cash-373.11259.78971.0910.47-45.82-21.57-167.88316.03-41.57
Free Cash Flow1,608.871,649.541,661.721,301.80573.63216.31634.01706.92390.34
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow25.3321.9028.1427.70102.17-88.6458.0498.70
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2027Q12026Q42026Q32026Q22026Q12025Q4
Cash & Short Term Investments1,029.171,472.591,665.991,426.391,391.871,222.53
Short Term Receivables1,024.421,084.951,045.941,047.04958.42990.67
Inventories1,021.36945.80911.88922.04945.81927.71
Other Current Assets433.97821.39440.25423.32329.64364.70
Total Current Assets3,508.924,324.744,064.063,818.803,625.743,505.61
Net Property, Plant & Equipment798.48735.00728.57730.17725.64718.29
Total Investments and Advances152.13157.38158.26144.14150.2070.45
Intangible Assets3,350.913,362.313,468.323,474.613,491.193,511.54
Deferred Tax Assets344.85329.25312.59285.91275.95253.12
Other Assets42.9943.2238.2435.3325.34100.81
Total Assets8,211.818,965.958,784.288,503.378,308.358,174.39
Short Term Debt Incl. Current Port. of LT Debt191.50289.09289.16289.67289.8740.41
Accounts Payable320.68308.92273.30250.41266.77278.16
Income Tax Payable160.2398.11163.32140.49135.24132.27
Other Current Liabilities651.81698.99625.43567.55563.61568.28
Total Current Liabilities1,324.221,395.111,351.211,248.111,255.501,019.12
Long Term Debt419.08536.83554.01558.06556.48811.41
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities62.6564.6477.9377.9977.5777.68
Other Liabilities458.17383.98309.23298.33297.54298.32
Total Liabilities2,264.122,380.562,292.372,182.492,187.092,206.53
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity5,947.696,585.396,491.916,320.886,121.265,967.86
Total Shareholders Equity5,947.696,585.396,491.916,320.886,121.265,967.86
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity5,947.696,585.396,491.916,320.886,121.265,967.86
Total Liabilities & Stockholders Equity8,211.818,965.958,784.288,503.378,308.358,174.39
Book Value Per Share42.2945.6644.7643.3941.9440.77
Tangible Book Value Per Share18.4622.3520.8519.5418.0216.78
Full-Time Employees-11,370---10,600
Price to Book Ratio5.544.355.175.746.716.83
Return on Assets19.2917.7718.5919.0018.5218.62
Return on Equity26.4024.2725.2525.6825.4125.86
Return on Invested Capital6.575.385.665.715.225.60
Quick Ratio1.882.422.332.322.132.53
Current Ratio2.653.103.013.062.893.44

Cash flow, quarterly

Currency USD, millions
Metric2027Q12026Q42026Q32026Q22026Q12025Q4
Net Income418.41383.43398.73392.59348.54379.70
Depreciation51.8355.1269.0362.3357.6774.29
Other Funds (Non Cash)-33.6724.4535.2027.1225.8626.02
Funds from Operations436.57463.00502.97482.04432.07480.01
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-14.15-8.3751.16-142.2925.2558.76
Cash from Operating Activities422.42454.63554.13339.75457.32538.77
Capital Expenditures-51.17-57.25-39.59-34.55-45.78-33.78
Net Assets From Acquisitions-7.49-325.32-24.880.00-0.52-138.58
Sale of Fixed Assets and Businesses450.820.000.000.000.000.00
Purchase or Sale of Investments-2.72-2.00-17.63-3.98-2.17-1.76
Purchase of Investments-2.72-2.00-20.13-4.23-2.17-2.01
Sale Or Maturity of Investments0.000.002.500.250.000.25
Other Uses0.000.0016.51-12.41-4.100.00
Other Sources2.620.927.560.000.0040.41
Cash from Investing Activities392.06-383.65-58.03-50.94-52.58-133.71
Cash Dividends Paid-94.95-87.09-87.24-87.58-87.75-77.59
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-932.72-170.69-167.59-145.46-141.81-69.85
Repurchase of Common Pref Stock-936.38-200.00-175.01-175.01-150.01-100.01
Sale of Common Pref Stock3.6529.317.4329.568.2130.16
Proceedsfrom Stock Options3.6529.317.4329.568.2130.16
Issuance or Reduction of Debt, Net-250.00-5.000.00-5.000.00-5.00
Change in Long Term Debt-250.00-5.000.00-5.000.00-5.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt-250.00-5.000.00-5.000.00-5.00
Net Financing Active Other Cash Flow-0.33-0.39-0.42-20.31-0.72-11.45
Other Financing Activities Uses-0.33-0.39-0.42-20.31-0.72-11.45
Cash from Financing Activities-1,278.00-263.16-255.24-258.35-230.27-163.89
Exchange Rate Effect5.030.912.582.77-0.0735.57
Net Change in Cash-458.49-191.28243.4433.22174.40276.74
Free Cash Flow373.68403.50520.48311.21414.36508.18
Price to Free Cash Flow25.3321.7323.1324.1327.7828.08

Revenue breakdown

Americas2025: 3.00B 2026: 3.28B
Consolidation, Policy2025: 641.44M 2026: 675.81M
Other countries2025: 1.51B 2026: 1.70B
Residential Care Software2025: 641.44M 2026: 675.81M
Sleep and Breathing Health2025: 4.50B 2026: 4.98B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-307.52%10.5M139.3M1.35M
2026-10-158.56%11.9M139.3M1.29M
2026-09-309.18%12.8M139.3M1.41M
2026-09-159.94%14.2M142.9M1.49M
2026-08-319.15%13.1M142.9M1.52M
2026-08-148.96%12.8M142.9M1.54M
2026-07-3110.91%15.7M143.7M1.53M
2026-07-159.42%13.5M143.7M1.55M
2026-06-3010.51%15.1M143.7M1.41M
2026-06-158.99%12.9M143.7M1.30M
2026-05-298.27%11.9M143.7M1.24M
2026-05-159.45%13.6M143.7M1.14M
2026-04-308.55%12.3M143.8M1.11M
2026-04-157.96%11.5M144.4M1.11M
2026-03-318.21%11.9M144.7M1.10M
2026-03-138.18%11.8M144.7M1.08M
2026-02-278.18%11.8M144.7M1.04M
2026-02-136.98%10.1M144.7M1.04M
2026-01-307.69%11.1M144.7M1.06M
2026-01-157.88%11.4M145.0M1.06M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call14591.5094.300.001.7540.000.000.986-0.1220.013
call15086.5089.300.001.6480.000.000.985-0.1220.014
call15581.5084.600.001.6590.000.000.984-0.1210.015
call16076.5079.300.001.4460.000.000.983-0.1200.015
call16571.7074.300.001.3480.000.000.982-0.1190.016
call17066.5069.300.001.2540.000.000.981-0.1180.017
call17561.7064.500.000.9820.000.000.979-0.1170.018
call18056.5059.300.001.0710.000.000.978-0.1160.020
call18551.5054.600.001.0660.000.000.976-0.1140.021
call19046.5049.100.000.8310.000.000.974-0.1130.022
call19541.5044.600.000.6110.000.000.971-0.1110.024
call20036.5039.1051.590.67019.000.000.968-0.1090.026
call21026.5029.4041.500.5805.000.000.923-0.1960.054
call22016.6019.3034.240.39413.000.000.898-0.1730.066
call2308.3010.509.360.34327.000.000.739-0.2810.121
call2402.604.102.850.3112284.000.473-0.3090.148
call2500.352.100.590.4071560.000.264-0.3110.121
call2600.101.500.250.32989.002.000.061-0.0900.045
call2700.000.950.100.44061.000.000.039-0.0790.031
call2800.001.150.580.5442880.000.033-0.0840.027
call2900.001.150.870.64023.000.000.028-0.0880.024
call3000.002.000.720.7303.000.000.025-0.0910.022
call3100.002.150.000.8160.000.000.023-0.0940.020
call3200.002.150.000.8970.000.000.021-0.0960.019
call3300.002.150.350.9751.000.000.020-0.0990.018
call3400.002.150.001.0490.000.000.019-0.1010.017
put1450.002.150.001.4780.000.00-0.014-0.1100.014
put1500.002.150.001.3920.000.00-0.015-0.1100.014
put1550.002.150.301.3030.000.00-0.016-0.1080.015
put1600.002.150.001.2230.000.00-0.017-0.1070.016
put1650.002.150.001.1460.000.00-0.018-0.1070.017
put1700.002.150.001.0860.000.00-0.019-0.1060.017
put1750.002.150.801.0164.000.00-0.020-0.1050.018
put1800.001.150.600.9362.000.00-0.022-0.1030.020
put1850.000.950.870.8571140.00-0.024-0.1010.021
put1900.001.200.150.7801010.00-0.026-0.0990.022
put1950.000.951.310.70520.000.00-0.029-0.0960.024
put2000.000.750.200.63046.000.00-0.032-0.0940.026
put2100.002.500.600.59856.000.00-0.077-0.1800.054
put2200.000.801.380.4274580.00-0.101-0.1550.066
put2301.802.654.710.4152330.00-0.261-0.2620.121
put2405.406.809.050.4142641.00-0.527-0.2900.148
put25012.5015.1014.030.55434.000.00-0.736-0.2900.121
put26021.3024.3026.400.7080.000.00-0.939-0.0680.045
put27031.4034.2031.100.8575.000.00-0.961-0.0560.031
put28041.1043.900.000.9430.000.00-0.967-0.0600.027
put29051.2053.900.001.0770.000.00-0.971-0.0630.024
put30061.5064.200.001.2760.000.00-0.974-0.0650.022
put31071.6073.900.001.3210.000.00-0.977-0.0670.020
put32081.4083.900.001.4320.000.00-0.978-0.0680.019
put33091.4093.900.001.5380.000.00-0.980-0.0690.018
put340101.3103.90.001.8150.000.00-0.981-0.0700.017

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-09144Filing for proposed sale of securities under Rule 144.SEC
2026-10-3010-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-298-KCurrent report2026-10-29SEC
2026-10-264Statement of changes in beneficial ownership of securities2026-10-23SEC
2026-10-23144Filing for proposed sale of securities under Rule 144.SEC
2026-10-084Statement of changes in beneficial ownership of securities2026-10-07SEC
2026-10-07144Filing for proposed sale of securities under Rule 144.SEC
2026-10-01ARSAnnual report to security holders. 2026-06-30SEC
2026-10-01DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-10-01DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-30SEC
2026-10-014/A2026-09-08SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-08-14SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-08-14SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-08-14SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-08-14SEC
2026-09-104Statement of changes in beneficial ownership of securities2026-09-08SEC
2026-09-08144Filing for proposed sale of securities under Rule 144.SEC
2026-09-044Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-09-02144Filing for proposed sale of securities under Rule 144.SEC
2026-09-018-KCurrent report2026-08-31SEC
2026-08-178-KCurrent report2026-08-13SEC
2026-08-1310-KAnnual report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-114Statement of changes in beneficial ownership of securities2026-08-07SEC
2026-08-07144Filing for proposed sale of securities under Rule 144.SEC
2026-08-07SCHEDULE 13GSEC
2026-08-068-KCurrent report2026-08-06SEC
2026-08-064Statement of changes in beneficial ownership of securities2026-08-05SEC
2026-08-05144Filing for proposed sale of securities under Rule 144.SEC
2026-07-094Statement of changes in beneficial ownership of securities2026-07-07SEC
2026-07-07144Filing for proposed sale of securities under Rule 144.SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-10001.23M2
2026-09001.34M2
2026-08002.83M2
2026-07001.09M1
2026-0600968.06K1
2026-05001.04M1
2026-04001.80M3
2026-03002.03M3
2026-02002.14M4
2026-01001.99M4
2025-12002.01M4
2025-11003.89M5

Institutional holders

Manager% owned
BlackRock, Inc.8.49%
VANGUARD CAPITAL MANAGEMENT LLC6.53%
VANGUARD PORTFOLIO MANAGEMENT LLC5.46%
STATE STREET CORP4.61%
GEODE CAPITAL MANAGEMENT, LLC3.06%
Bank of New York Mellon Corp2.59%
FIRST TRUST ADVISORS LP1.57%
Invesco Ltd.1.42%
MORGAN STANLEY1.33%
NORTHERN TRUST CORP1.17%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND3.17%
VANGUARD 500 INDEX FUND2.59%
VANGUARD MID-CAP INDEX FUND2.17%
iShares Core S&P 500 ETF1.38%
Fidelity 500 Index Fund1.31%
VANGUARD GROWTH INDEX FUND1.29%
SPDR S&P 500 ETF TRUST1.21%
First Trust Rising Dividend Achievers ETF0.96%
VANGUARD MID-CAP GROWTH INDEX FUND0.77%
State Street(R) Health Care Select Sector SPDR(R) ETF0.71%

OakChart. RMD. Cached 15 minutes.